Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Rowe

Showing results (221-230 of 459) with videos related to

Pageof 46
Sort By:
Annals of Neurology|September 20, 2020
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear PalsyMaura Malpetti, Luca Passamonti, Timothy Rittman, et al.
Annals of Clinical and Translational Neurology|March 9, 2019
In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrierW Richard Bevan-Jones, Thomas E Cope, P Simon Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degenerationLaura E Hughes, Natalie E Adams, Matthew A Rouse, et al.
Brain : a Journal of Neurology|November 3, 2020
GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibitionAlexander G Murley, Matthew A Rouse, P Simon Jones, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2018
Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humansNikolina Skandali, James B Rowe, Valerie Voon, et al.
Brain Communications|October 28, 2024
Noradrenergic modulation of saccades in Parkinson's diseaseIsabella F Orlando, Frank H Hezemans, Rong Ye, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
A robust harmonization approach for cognitive data from multiple aging and dementia cohortsJoseph Giorgio, Ankeet Tanna, Maura Malpetti, et al.
Biological Psychiatry|March 25, 2014
Improving response inhibition in Parkinson's disease with atomoxetineZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Neurology|April 3, 2016
Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromesIan T S Coyle-Gilchrist, Katrina M Dick, Karalyn Patterson, et al.
Brain : a Journal of Neurology|March 1, 2014
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's diseaseZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Pageof 46

Showing results (221-230 of 459) with videos related to

Sort By:
Pageof 46
Annals of Neurology|September 20, 2020
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear PalsyMaura Malpetti, Luca Passamonti, Timothy Rittman, et al.
Annals of Clinical and Translational Neurology|March 9, 2019
In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrierW Richard Bevan-Jones, Thomas E Cope, P Simon Jones, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
GABAergic modulation of beta power enhances motor adaptation in frontotemporal lobar degenerationLaura E Hughes, Natalie E Adams, Matthew A Rouse, et al.
Brain : a Journal of Neurology|November 3, 2020
GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibitionAlexander G Murley, Matthew A Rouse, P Simon Jones, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2018
Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humansNikolina Skandali, James B Rowe, Valerie Voon, et al.
Brain Communications|October 28, 2024
Noradrenergic modulation of saccades in Parkinson's diseaseIsabella F Orlando, Frank H Hezemans, Rong Ye, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 28, 2023
A robust harmonization approach for cognitive data from multiple aging and dementia cohortsJoseph Giorgio, Ankeet Tanna, Maura Malpetti, et al.
Biological Psychiatry|March 25, 2014
Improving response inhibition in Parkinson's disease with atomoxetineZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Neurology|April 3, 2016
Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromesIan T S Coyle-Gilchrist, Katrina M Dick, Karalyn Patterson, et al.
Brain : a Journal of Neurology|March 1, 2014
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's diseaseZheng Ye, Ellemarije Altena, Cristina Nombela, et al.
Pageof 46